» Articles » PMID: 9351981

Down-regulation of Mu-opioid Receptor by Full but Not Partial Agonists is Independent of G Protein Coupling

Overview
Journal Mol Pharmacol
Date 1997 Nov 14
PMID 9351981
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In C6 glial cells stably expressing rat mu-opioid receptor, opioid agonist activation is negatively coupled to adenylyl cyclase through pertussis toxin-sensitive G proteins. In membranes, [D-Ala2, N-MePhe4,Gly-ol5]enkephalin (DAMGO) increases guanosine-5'-O-(3-[35S]thio)triphosphate (GTP[gamma-35S]) binding by 367% with an EC50 value of 28 nM. Prolonged exposure to agonists induced desensitization of the receptor as estimated by a reduction in the maximal stimulation of GTP[gamma-35S] binding by DAMGO and rightward shifts in the dose-response curves. In cells treated with 10 microM concentrations of etorphine, DAMGO, beta-endorphin, morphine, and butorphanol, DAMGO-stimulated GTP[gamma-35S] binding was 58%, 149%, 205%, 286%, and 325%, respectively. Guanine nucleotide regulation of agonist binding was correspondingly lower in membranes from tolerant cells. Furthermore, chronic opioid treatment increased forskolin-stimulated adenylyl cyclase activity, and potency of DAMGO to inhibit cAMP accumulation was lower in morphine- and DAMGO-tolerant cells (EC50 = 55 and 170 nM versus 18 nM for control). Chronic treatment with agonists reduced [3H]DAMGO binding in membranes with the rank order of etorphine > DAMGO = beta-endorphin > morphine > butorphanol, and the affinity of DAMGO in alkaloid- but not peptide-treated membranes was significantly lower in comparison with control. Pertussis toxin treatment of the cells before agonist treatment did not prevent the down-regulation by full agonists; DAMGO and etorphine exhibited approximately 80% internalization, whereas the ability of partial agonists was greatly impaired. In addition to establishing this cell line as a good model for further studies on the mechanisms of opioid tolerance, these results indicate important differences in the inactivation pathways of receptor triggered by full and partial agonists.

Citing Articles

Sex-dependent impact of microbiota status on cerebral μ-opioid receptor density in fischer rats.

Effah F, de Gusmao Taveiros Silva N, Vijayanathan K, Camarini R, Joly F, Taiwo B Eur J Neurosci. 2022; 55(8):1917-1933.

PMID: 35393704 PMC: 9324823. DOI: 10.1111/ejn.15666.


Activation of nucleus accumbens μ-opioid receptors enhances the response to a glycaemic challenge.

Koekkoek L, Kool T, Eggels L, van der Gun L, Lamuadni K, Slomp M J Neuroendocrinol. 2021; 33(10):e13036.

PMID: 34528311 PMC: 9286654. DOI: 10.1111/jne.13036.


Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord.

Chen W, Ennes H, McRoberts J, Marvizon J Neuropharmacology. 2017; 128:255-268.

PMID: 29042318 PMC: 5726399. DOI: 10.1016/j.neuropharm.2017.10.014.


μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.

Chen W, McRoberts J, Marvizon J Neuroscience. 2014; 267:67-82.

PMID: 24583035 PMC: 3998911. DOI: 10.1016/j.neuroscience.2014.02.023.


The combination of mitragynine and morphine prevents the development of morphine tolerance in mice.

Fakurazi S, Rahman S, Taufik Hidayat M, Ithnin H, Mohd Moklas M, Arulselvan P Molecules. 2013; 18(1):666-81.

PMID: 23292329 PMC: 6270191. DOI: 10.3390/molecules18010666.